Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2761711 | 0.83 | MEN1 (0.32) | MEN1CDC25BKMT2A | |
| SCHEMBL322239 | 0.80 | MEN1 (0.35) | MEN1CDC25BKMT2A | |
| SCHEMBL8855149 | 0.80 | MEN1 (0.35) | MEN1CDC25BKMT2A | |
| SCHEMBL10505006 | 0.76 | HDAC4 (0.38) | MEN1CDC25BKMT2A | |
| SCHEMBL11552312 | 0.74 | — | — | |
| SCHEMBL115447 | 0.74 | CYP3A4 (0.33) | — | |
| SCHEMBL3222569 | 0.74 | GABRA1 (0.40) | — | |
| SCHEMBL9729872 | 0.73 | — | — | |
| SCHEMBL335714 | 0.73 | MEN1 (0.37) | MEN1KMT2A | |
| SCHEMBL981109 | 0.73 | TSHR (0.39) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 599 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024115460-A1 | BINAPHTHYL COMPOUNDS AND THERMOPLASTIC RESINS | REUTER CHEMISCHE APPARATEBAU E.K. (DE) | 2024-06-06 | — | — | WO | claimed |
| WO-2024068860-A1 | OLIGOMERIC BINAPHTYL COMPOUNDS AND THERMOPLASTIC RESINS | REUTER CHEMISCHE APPARATEBAU E.K. (DE) | 2024-04-04 | — | — | WO | claimed |
| US-8580478-B2 | Latent acids and their use | BASF SE (DE) | 2013-11-12 | — | — | US | claimed |
| EP-1472576-B1 | SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2013-04-24 | — | — | EP | claimed |
| EP-2349993-B1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2012-12-12 | — | — | EP | claimed |
| US-8241822-B2 | Halogenated oxime derivatives and the use therof as latent acids | BASF SE (DE) | 2012-08-14 | — | — | US | claimed |
| US-20110300484-A1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2011-12-08 | — | — | US | claimed |
| US-20110217654-A1 | Latent acids and their use | BASF SE (DE) | 2011-09-08 | — | — | US | claimed |
| EP-2349993-A1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2011-08-03 | — | — | EP | claimed |
| US-20110171569-A1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2011-07-14 | — | — | US | claimed |
| EP-0139609-A1 | Process for curing acid-curable lacquers | CIBA-GEIGY AG (CH) | 1985-05-02 | — | — | EP | claimed |
| US-4451408-A | Process of preparing sulfonium organosulfonates | THE DOW CHEMICAL COMPANY (US) | 1984-05-29 | — | — | US | claimed |
| US-4451409-A | Sulfonium organosulfonates | THE DOW CHEMICAL COMPANY (US) | 1984-05-29 | — | — | US | claimed |
| EP-0105644-A2 | Azocarboxylate blowing agent | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1984-04-18 | — | — | EP | claimed |
| US-4414364-A | ENDCAPPING WITH A HALOHYDROCARBON OR A TRIALKYL SILICON HALIDE | MCALISTER ROY E | 1983-11-08 | — | — | US | claimed |
| US-4202816-A | ENOL-PIPERIDINE METAL COMPLEXES | CIBA-GEIGY CORPORATION (US) | 1980-05-13 | — | — | US | claimed |
| US-4196298-A | Cyclic sulfonium ylids | THE DOW CHEMICAL COMPANY (US) | 1980-04-01 | — | — | US | claimed |
| US-4129570-A | EXCELLENT THERMAL AND MECHANICAL PROPERTIES AT HIGH TEMPERATURES | HUGHES AIRCRAFT COMPANY (US) | 1978-12-12 | — | — | US | claimed |
| US-4096100-A | Blowing agents-bis(hydrocarbylsulfonyl) carbohydrazides | UNIROYAL, INC. (US) | 1978-06-20 | — | — | US | claimed |
| US-3946064-A | EXPANDING POLYMERS | UNIROYAL, INC. (US) | 1976-03-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110217654-A1 | Latent acids and their use | NR1H3, NR1H2, NR2E3 | MEN1 4134/4885CDC25B 3185/4885KMT2A 3052/4885 |
| US-20110300484-A1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | AHR, ARSA, TDO2 | MEN1 2179/4885CDC25B 2247/4885KMT2A 3971/4885 |
| US-20110171569-A1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | NR2E3, HCAR3, HRH4 | MEN1 3293/4885CDC25B 3467/4885KMT2A 3992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.